Phosphate levels and cardiovascular disease in the general population
- PMID: 19423568
- DOI: 10.2215/CJN.01660309
Phosphate levels and cardiovascular disease in the general population
Abstract
Phosphate levels are consistently linked with cardiac calcification, cardiovascular disease (CVD), and death in populations with chronic kidney disease. In addition, mechanistic insights suggest that phosphate levels that span the conventional normal range could lead to CVD. Examining these associations in the general population may be relevant because several interventions that may be suitable for primary or secondary prevention trials already exist. This review summarizes findings described from several community-based, prospective, observational studies. Graded associations with cardiac calcification, left ventricular hypertrophy, cardiovascular events, and death were evident, and cardiovascular risk seemed to accelerate with phosphate >3.5 to 4.0 mg/dl. Although the cause of these associations remains to be determined, several existing interventions may allow in-depth examination of the hypothesis that reducing phosphate levels could prevent CVD in the general population. Even as proof-of-concept trials and mechanistic studies are awaited, phosphate levels may be useful for cardiovascular risk stratification in adults without overt kidney disease.
Similar articles
-
Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.Clin J Am Soc Nephrol. 2010 Jan;5 Suppl 1:S41-7. doi: 10.2215/CJN.05860809. Clin J Am Soc Nephrol. 2010. PMID: 20089502 Review.
-
Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.Ther Adv Cardiovasc Dis. 2007 Dec;1(2):107-12. doi: 10.1177/1753944707085444. Ther Adv Cardiovasc Dis. 2007. PMID: 19124399 Review.
-
Phosphate: a stealthier killer than previously thought?Cardiovasc Pathol. 2012 Sep-Oct;21(5):372-81. doi: 10.1016/j.carpath.2012.02.008. Epub 2012 Mar 16. Cardiovasc Pathol. 2012. PMID: 22425627 Review.
-
Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.Nephrology (Carlton). 2012 Jul;17(5):433-44. doi: 10.1111/j.1440-1797.2012.01618.x. Nephrology (Carlton). 2012. PMID: 22574672 Review.
-
Cardiovascular disease in chronic kidney disease.Ther Adv Cardiovasc Dis. 2008 Dec;2(6):425-34. doi: 10.1177/1753944708096379. Ther Adv Cardiovasc Dis. 2008. PMID: 19124439 Review.
Cited by
-
Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study.Clin Nephrol. 2012 Jul;78(1):1-9. doi: 10.5414/cn106830. Clin Nephrol. 2012. PMID: 22732331 Free PMC article. Clinical Trial.
-
Autophagy Protects From Uremic Vascular Media Calcification.Front Immunol. 2018 Aug 14;9:1866. doi: 10.3389/fimmu.2018.01866. eCollection 2018. Front Immunol. 2018. PMID: 30154792 Free PMC article.
-
Higher Intra-Dialysis Serum Phosphorus Reduction Ratio as a Predictor of Mortality in Patients on Long-Term Hemodialysis.Med Sci Monit. 2019 Jan 24;25:691-699. doi: 10.12659/MSM.913137. Med Sci Monit. 2019. PMID: 30674864 Free PMC article.
-
Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study.Am Heart J. 2014 Feb;167(2):141-149.e2. doi: 10.1016/j.ahj.2013.10.024. Epub 2013 Nov 6. Am Heart J. 2014. PMID: 24439974 Free PMC article. Clinical Trial.
-
Liver X receptor-activating ligands modulate renal and intestinal sodium-phosphate transporters.Kidney Int. 2011 Sep;80(5):535-44. doi: 10.1038/ki.2011.159. Epub 2011 Jun 15. Kidney Int. 2011. PMID: 21677638 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
